Abelardo Meneses García, General Director at the National Cancer Institute of Mexico (INCan), explains the evolution of cancer’s footprint in Mexico and showcases how the institute has been investing in enlarging its capabilities to become the national and regional reference for cancer treatment.
Could you please introduce to our international readers the key activities and responsibilities of the institute?
"Throughout its history of more than 70 years, the institute has always aimed to be the leader in setting national public policies affecting the diagnostics, treatment, palliative care, and rehabilitation of cancer."
